Next, we examined the expression of full-length BBF2H7 and its cleaved N- and C-terminus in lysates of the following cancer cell lines: glioblastoma U251MG, breast cancer MCF7, cervical cancer HeLa, prostate cancer LNCap and colon cancer LS174T. Here, CREB3L2 is linked to glioblastoma.